Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Financings Of The Fortnight: Too Soon To Size Up Impact Of The U.S. JOBS Act

Jan 25 2013

• By Alex Lash, Stacy Lawrence, and Paul Bonanos

Related Content

In the Midst Of A Shakeout, Biotech VCs Must Embrace New Partners, New Math

Sep 01 2010

No Longer Aiming To Partner At Proof-of-Concept, Flexion Raises $20M For Late-Stage Trials

Dec 04 2012

After Pirfenidone: Broad Competition To Bring First Therapy For Underlying Cause Of IPF To Market

Mar 26 2012

Onyx <em>Kyprolis</em> Launch Strategy Includes Speedy Delivery, Premium Price

Jul 20 2012

Related Companies

Onyx Pharmaceuticals, Inc.

InterMune, Inc.

ArmaGen, Inc.

Avelas Biosciences, Inc.

Cibiem Inc.

Enterome SA

Galera Therapeutics, Inc.

Global Blood Therapeutics, Inc.

Intact Vascular Inc.

Solstice Biologics LLC

Warp Drive Bio, Inc.

Alexion Pharmaceuticals Inc.

Aravive, Inc.

Diartis Pharmaceuticals, Inc.

Amunix Pharmaceuticals, Inc.

Intarcia Therapeutics, Inc.

Flexion Therapeutics, Inc.

Rein Therapeutics, Inc.

Harvard University

GSK plc

Additional Topics

Business Strategies BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window